Badger Spf 35 All Season Face

Badger Spf 35 All Season Face Manufacturers

• Norwood Packaging Ltd.
  

  ×

  Badger Spf 35 All Season Face | Norwood Packaging Ltd.

  

  ---

  For full protection, apply liberally (2mg/cm2 of skin) to exposed skin 15 minutes before sun exposure, then rub in to reduce whitening effect. Reapply After 80 minutes of swimming or sweating Immediately after towel drying At least every 2 hours Sun Protection Measures Spending time in the sun increases your risk of skin cancer and early skin aging To decrease this risk, regularly use a sunscreen with Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10am-2pm Wear long-sleeved shirts, pants, hats, and sunglasses For children under 6 months of age: ask a doctor.

  Close
  No Recall

  More Info
• W.s. Badger Company, Inc.
  

  ×

  Badger Spf 35 All Season Face | Kremers Urban Pharmaceuticals Inc.

  

  ---

  Methylphenidate HCl Extended-Release Capsules CD is administered once daily in the morning, before breakfast.

  Methylphenidate HCl Extended-Release Capsules CD may be swallowed whole with the aid of liquids, or alternatively, the capsule may be opened and the capsule contents sprinkled onto a small amount (tablespoon) of applesauce and given immediately, and not stored for future use. Drinking some fluids, e.g. water, should follow the intake of the sprinkles with applesauce. The capsules and the capsule contents must not be crushed or chewed (see PRECAUTIONS: Information For Patients). Patients should be advised to avoid alcohol while taking Methylphenidate HCl Extended-Release Capsules CD.

  Dosage should be individualized according to the needs and responses of the patient.

  Initial Treatment

  The recommended starting dose of Methylphenidate HCl Extended-Release Capsules CD is 20 mg once daily. Dosage may be adjusted in weekly 10-20 mg increments to a maximum of 60 mg/day taken once daily in the morning, depending upon tolerability and degree of efficacy observed. Daily dosage above 60 mg is not recommended.

  Maintenance/Extended Treatment

  There is no body of evidence available from controlled trials to indicate how long the patient with ADHD should be treated with Methylphenidate HCl Extended-Release Capsules CD. It is generally agreed, however, that pharmacological treatment of ADHD may be needed for extended periods. Nevertheless, the physician who elects to use Methylphenidate HCl Extended-Release Capsules CD for extended periods in patients with ADHD should periodically re-evaluate the long-term usefulness of the drug for the individual patient with trials off medication to assess the patient's functioning without pharmacotherapy. Improvement may be sustained when the drug is either temporarily or permanently discontinued.

  Dose Reduction And Discontinuation

  If paradoxical aggravation of symptoms or other adverse events occur, the dosage should be reduced, or, if necessary, the drug should be discontinued.

  If improvement is not observed after appropriate dosage adjustment over a one-month period, the drug should be discontinued.

  Close
  No Recall

  More Info